Overview Incyte is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapeutics. Our global headquarters is located in Wilmington, Delaware, where we conduct discovery, clinical development and commercial operations. We also conduct clinical development and commercial operations from our European headquarters in Morges, Switzerland, and our other offices across Europe, as well as our Japanese headquarters in Tokyo and our Canadian hea...
Q2 FY2026 — expected 2026-08-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-10 | 2025-12-31 | 0000879169-26-000010 | EDGAR | 78K words |
| 2025-02-10 | 2024-12-31 | 0001628280-25-004633 | EDGAR | — |
| 2024-02-13 | 2023-12-31 | 0000879169-24-000045 | EDGAR | — |
| 2023-02-07 | 2022-12-31 | 0000879169-23-000008 | EDGAR | — |
| 2022-02-08 | 2021-12-31 | 0001558370-22-000902 | EDGAR | — |
| 2021-02-09 | 2020-12-31 | 0001558370-21-000825 | EDGAR | — |
| 2020-02-13 | 2019-12-31 | 0001558370-20-000774 | EDGAR | — |
| 2019-02-14 | 2018-12-31 | 0001558370-19-000682 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-28 | 2025-09-30 | 0000879169-25-000118 | EDGAR | 51K words |
| 2025-07-29 | 2025-06-30 | 0000879169-25-000103 | EDGAR | — |
| 2025-04-29 | 2025-03-31 | 0000879169-25-000056 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0000879169-24-000172 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0000879169-24-000149 | EDGAR | — |
| 2024-04-30 | 2024-03-31 | 0000879169-24-000077 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0000879169-23-000041 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0000879169-23-000025 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0000879169-23-000016 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0000879169-22-000010 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001558370-22-011631 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001558370-22-006808 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0000879169-26-000018 | EDGAR | 1K words |
| 2026-03-26 | 0000879169-26-000016 | EDGAR | — |
| 2026-03-06 | 0000879169-26-000013 | EDGAR | — |
| 2026-02-10 | 0000879169-26-000006 | EDGAR | — |
| 2025-12-12 | 0000879169-25-000122 | EDGAR | — |
| 2025-10-28 | 0000879169-25-000115 | EDGAR | — |
| 2025-10-03 | 0001104659-25-096632 | EDGAR | — |
| 2025-08-07 | 0000879169-25-000108 | EDGAR | — |
| 2025-07-29 | 0000879169-25-000100 | EDGAR | — |
| 2025-06-27 | 0001104659-25-063675 | EDGAR | — |
103 total filings indexed. 73 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000879169 |
| Ticker | INCY |
| Exchange | Nasdaq |
| SIC | 8731: Services-Commercial Physical & Biological Research |
| Incorporated | DE |
| Website | https://www.incyte.com |
| Listed | 1993-11-03 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report